SCHEMBL20786648

SCHEMBL20786648

C=CCCOc1cc([N+](=O)[O-])ccc1OCOC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
HPGD P15428 4/20 0.45
RAB9A P51151 3/20 0.45
CYP2D6 P10635 3/20 0.45
NPC1 O15118 2/20 0.45
CYP1A2 P05177 2/20 0.45
CYP3A4 P08684 2/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
ALDH1A1 P00352 5/20 0.43
LMNA P02545 4/20 0.43
KMT2A Q03164 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
HTT P42858 2/20 0.41
TDP1 Q9NUW8 2/20 0.40
CYP19A1 P11511 2/20 0.40
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27593208 0.82 HTT (0.46) MAPTSMN1; SMN2HPGDRAB9ACYP2D6
SCHEMBL18087973 0.81 HTT (0.58) MAPTSMN1; SMN2HPGDRAB9ACYP2D6
SCHEMBL5407163 0.81 HTT (0.58) MAPTSMN1; SMN2HPGDRAB9ACYP2D6
SCHEMBL30235266 0.81 HTT (0.58) MAPTSMN1; SMN2HPGDRAB9ACYP2D6
SCHEMBL2002273 0.79 MAPT (0.55) MAPTSMN1; SMN2HPGDRAB9ACYP2D6
SCHEMBL28614014 0.79 HTT (0.45) MAPTSMN1; SMN2HPGDRAB9ACYP2D6
SCHEMBL3696729 0.79 S1PR4 (0.56) MAPTSMN1; SMN2HPGDRAB9ACYP2D6
SCHEMBL3702075 0.79 RAB9A (0.60) MAPTSMN1; SMN2HPGDRAB9ACYP2D6
SCHEMBL5642158 0.78 RAB9A (0.45) MAPTSMN1; SMN2RAB9ACYP2D6NPC1
SCHEMBL14101860 0.77 ERN1 (0.50) MAPTSMN1; SMN2HPGDRAB9ACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109422737-B Imidazolone androgen receptor antagonist, preparation method and application thereof 上海时莱生物技术有限公司 2021-07-30 CN disclosed
WO-2019037742-A1 IMIDAZOLONE ANDROGEN RECEPTOR ANTAGONIST, PREPARATION METHOD THEREFOR AND USE THEREOF 上海时莱生物技术有限公司 2019-02-28 WO disclosed